Stay updated on Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.

Latest updates to the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page
- Check5 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check25 days agoChange DetectedDENIVOS study page now renders a 403 Forbidden error, replacing the usual detailed study information with an error view. The content sections such as history, eligibility criteria, and outcome measures are no longer visible.SummaryDifference17%

- Check47 days agoChange DetectedA funding attribution for 2018 (NIH grant/contract) was added, and the page revision label was updated from v3.6.5 to v3.6.6 to reflect the current version.SummaryDifference0.1%

- Check68 days agoChange DetectedThe revision marker at the bottom was updated from v3.6.4 to v3.6.5, signaling a maintenance update to the Study Details page. This change reflects a small backend or content refresh rather than a substantive change to the trial information.SummaryDifference0.0%

- Check83 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a recent site update without changes to the study information.SummaryDifference0.0%

- Check104 days agoChange DetectedThe page revision label changed from v3.6.2 to v3.6.3, reflecting an updated version of the page content.SummaryDifference0.0%

Stay in the know with updates to Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.